These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 2752520)
1. Ultraviolet irradiation produces cytotoxic synergy and increased DNA interstrand crosslinking with cis- and trans-diamminedichloroplatinum(II). Swinnen LJ; Fisher SG; Erickson LC Carcinogenesis; 1989 Aug; 10(8):1465-70. PubMed ID: 2752520 [TBL] [Abstract][Full Text] [Related]
2. cis-Diamminedichloroplatinum(II) (DDP)-induced crosslinking and crosslink removal in L1210 cells in vitro after theophylline co-treatment. Ducore JM Biochem Pharmacol; 1986 Feb; 35(4):607-11. PubMed ID: 3947390 [TBL] [Abstract][Full Text] [Related]
3. 1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking. Swinnen LJ; Barnes DM; Fisher SG; Albain KS; Fisher RI; Erickson LC Cancer Res; 1989 Mar; 49(6):1383-9. PubMed ID: 2924295 [TBL] [Abstract][Full Text] [Related]
4. The significance of DNA cross-linking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells. Strandberg MC; Bresnick E; Eastman A Chem Biol Interact; 1982 Mar; 39(2):169-80. PubMed ID: 7199396 [TBL] [Abstract][Full Text] [Related]
5. Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells. Fram RJ; Woda BA; Wilson JM; Robichaud N Cancer Res; 1990 Jan; 50(1):72-7. PubMed ID: 2293559 [TBL] [Abstract][Full Text] [Related]
6. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity. Vadi H; Drewinko B Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II)-induced DNA interstand cross-link removal and potentiation of cis-diammine-1,1-cyclobutane dicarboxylatoplatinum(II) cytotoxicity by hydroxyurea and 1-beta-D-arabinofuranosylcytosine. Swinnen LJ; Ellis NK; Erickson LC Cancer Res; 1991 Apr; 51(8):1984-9. PubMed ID: 2009517 [TBL] [Abstract][Full Text] [Related]
8. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts. Roberts JJ; Friedlos F Cancer Res; 1987 Jan; 47(1):31-6. PubMed ID: 3791217 [TBL] [Abstract][Full Text] [Related]
9. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids. Lippert B Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842 [TBL] [Abstract][Full Text] [Related]
10. Cis-diamminedichloroplatinum(II) toxicity in human melanoma cells and lymphocytes as related to cellular platinum accumulation, DNA cross-linking and inhibition of DNA synthesis. Hansson J; Lewensohn R; Ringborg U Acta Oncol; 1988; 27(4):383-92. PubMed ID: 3202996 [TBL] [Abstract][Full Text] [Related]
11. Formation and repair of 1,3-bis-(2-chloroethyl)-1-nitrosourea and cisplatin induced total genomic DNA interstrand crosslinks in human glioma cells. Ali-Osman F; Rairkar A; Young P Cancer Biochem Biophys; 1995 Jan; 14(4):231-41. PubMed ID: 7767897 [TBL] [Abstract][Full Text] [Related]
12. Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition. Bodenner DL; Dedon PC; Keng PC; Borch RF Cancer Res; 1986 Jun; 46(6):2745-50. PubMed ID: 2870800 [TBL] [Abstract][Full Text] [Related]
13. A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells. Micetich KC; Barnes D; Erickson LC Cancer Res; 1985 Sep; 45(9):4043-7. PubMed ID: 3896476 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of synergism of drugs cis-diamminedichloroplatinum (II) and arabinosylcytosine on the level of chemical interaction with DNA and on the growth of mouse leukemia. Rauko P; Novotný L; Reichelová V; Balázová E Gen Pharmacol; 1991; 22(5):805-10. PubMed ID: 1761184 [TBL] [Abstract][Full Text] [Related]
15. Repair synthesis by human cell extracts in cisplatin-damaged DNA is preferentially determined by minor adducts. Calsou P; Frit P; Salles B Nucleic Acids Res; 1992 Dec; 20(23):6363-8. PubMed ID: 1475197 [TBL] [Abstract][Full Text] [Related]
16. Crosslinking of chromosomal proteins to DNA in HeLa cells by UV gamma radiation and some antitumor drugs. Banjar ZM; Hnilica LS; Briggs RC; Stein J; Stein G Biochem Biophys Res Commun; 1983 Jul; 114(2):767-73. PubMed ID: 6683966 [TBL] [Abstract][Full Text] [Related]
18. Role of carrier ligand in platinum resistance of human carcinoma cell lines. Schmidt W; Chaney SG Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361 [TBL] [Abstract][Full Text] [Related]
19. Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum. Terheggen PM; Emondt JY; Floot BG; Dijkman R; Schrier PI; den Engelse L; Begg AC Cancer Res; 1990 Jun; 50(12):3556-61. PubMed ID: 2340504 [TBL] [Abstract][Full Text] [Related]
20. Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro. Poirier MC; Lippard SJ; Zwelling LA; Ushay HM; Kerrigan D; Thill CC; Santella RM; Grunberger D; Yuspa SH Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6443-7. PubMed ID: 6959129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]